货币 / ASND
ASND: Ascendis Pharma A/S - American Depositary Shares
170.14
USD
4.14
(2.49%)
今日ASND汇率已更改2.49%。当日,交易品种以低点166.00和高点171.19进行交易。
关注Ascendis Pharma A/S - American Depositary Shares动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ASND新闻
- Zacks Wall Street Analysts Believe Ascendis Pharma (ASND) Could Rally 29.83%: Here's is How to Trade
- Investing BioMarin stock maintains Outperform rating at Wolfe Research amid PKU market competition
- Investing Ascendis reports positive 3-year data for TransCon PTH in hypoparathyroidism
- Investing Alibaba, Merck Stir Wednesday’s Market Cap Stock Movers
- Investing Alibaba, Merck Lead Market Cap Stock Movers on Wednesday
- Investing Ascendis Pharma stock rating assumed at Overweight by Morgan Stanley
- Seeking Alpha Touchstone Mid Cap Growth Fund Q1 2025 Commentary (TEGAX)
- Investing UBS reiterates buy rating on Ascendis Pharma stock citing strong launch
- Investing BioMarin stock maintains Buy rating at Jefferies amid exclusivity battle
- Investing Tesla, Nvidia Lead Market Cap Stock Movers on Wednesday
- Investing Ascendis Pharma price target raised to $224 on strong Yorvipath demand
- Investing Stifel reiterates buy rating on MBX Biosciences stock ahead of trial data
- Seeking Alpha Artisan Global Discovery Fund Q1 2025 Commentary
- Investing TD Cowen maintains Buy rating on Ascendis Pharma stock
- Investing RBC Capital maintains outperform rating for Ascendis Pharma stock
- Investing Canaccord holds Ascendis Pharma stock at $84 target
- Investing BofA raises Ascendis Pharma stock target to $216
- Investing TransCon ® hGH Boosted Treatment Benefits of TransCon ® CNP in Children with Achondroplasia at Week 26 Interim Analysis of the Phase 2 COACH Trial
- Seeking Alpha Harbor Health Care ETF Q1 2025 Commentary (undefined:MEDI)
- Investing Meta and Biontech Lead Market Cap Stock Movers on Monday
- Investing BofA Securities raises Ascendis Pharma stock price target to $201
- Investing Ascendis Pharma stock rises following FDA priority review
- Investing FDA prioritizes review of Ascendis Pharma’s growth disorder drug
- Investing Miniso Group reports regulatory filings for May 2025
日范围
166.00
171.19
年范围
111.09
183.00
- 前一天收盘价
- 165.54
- 开盘价
- 166.00
- 卖价
- 170.14
- 买价
- 170.44
- 最低价
- 166.00
- 最高价
- 171.19
- 交易量
- 1.242 K
- 日变化
- 2.49%
- 月变化
- -0.37%
- 6个月变化
- 34.13%
- 年变化
- 27.31%
24 七月, 星期四
12:30
USD
- 实际值
- 预测值
- -0.12
- 前值
- -0.28
12:30
USD
- 实际值
- 预测值
- 215 K
- 前值
- 221 K
12:30
USD
- 实际值
- 预测值
- 1.972 M
- 前值
- 1.956 M
12:30
USD
- 实际值
- 预测值
- 225.813 K
- 前值
- 229.500 K
14:00
USD
- 实际值
- 预测值
- 0.684 M
- 前值
- 0.623 M
14:00
USD
- 实际值
- 预测值
- -3.2%
- 前值
- -13.7%
14:30
USD
- 实际值
- 预测值
- 20 B
- 前值
- 46 B
15:00
USD
- 实际值
- 预测值
- -2
- 前值
- -2
15:00
USD
- 实际值
- 预测值
- -5
- 前值
- 5
15:30
USD
- 实际值
- 预测值
- 前值
- 4.230%
15:30
USD
- 实际值
- 预测值
- 前值
- 4.270%
17:00
USD
- 实际值
- 预测值
- 前值
- 2.220%